Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 91 (3), 526-533
- https://doi.org/10.1016/j.ygyno.2003.07.002
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The histological diagnosis of endometrial hyperplasiaVirchows Archiv, 2001
- Prospective Multicenter Evaluation of the Morphometric D-Score for Prediction of the Outcome of Endometrial HyperplasiasThe American Journal of Surgical Pathology, 2001
- Reproducibility of the Diagnosis of Endometrial Hyperplasia, Atypical Hyperplasia, and Well-Differentiated CarcinomaThe American Journal of Surgical Pathology, 1998
- Progestin Treatment of Atypical Hyperplasia and Well-Differentiated Carcinoma of the Endometrium in Women Under Age 40Obstetrics & Gynecology, 1997
- The levonorgestrel intrauterine system in the management of menorrhagiaBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagiaBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasiaAmerican Journal of Obstetrics and Gynecology, 1989
- Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features aloneThe Journal of Pathology, 1988
- The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patientsCancer, 1985
- TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUDClinical Endocrinology, 1982